Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
We describe a patient with poorly controlled, multidrug-resistant human immunodeficiency virus disease who developed >20 skin lesions caused by Paecilomyces lilacinus. The lesions failed to improve during treatment with oral itraconazole, amphotericin B, and amphotericin B lipid complex but improved during treatment with voriconazole.
Martin
Craig A
CA
Pharmacy Services, University of Kentucky Medical Center, Lexington, USA.
Roberts
Sara
S
Greenberg
Richard N
RN
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000382:microbiology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000382:microbiology*; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009181:Mycoses / Q000188:drug therapy*; D010143:Paecilomyces / Q000187:drug effects; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole